Multiple Sclerosis Trial, Recruiting NCT06197685 Sponsor: Kessler Foundation Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT06197685
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 18 and 70 years of age
  • People whose primary language is English
  • People who have been formally diagnosed with multiple sclerosis (MS) by a neurologist
  • People who have not had a relapse or taken steroids for at least 30 days
  • People with mild-to-moderate self-reported difficulty with movement or mobility, based on a specific MS disability scale (called the PDDS)
  • People who are currently not regularly physically active, based on a standard exercise questionnaire (called the GLTEQ)
  • People who are right-handed

Who may not be able to join:

  • People who have a history of neurological conditions other than MS, or who have uncontrolled mental health conditions such as major depression
  • People for whom exercise may not be medically safe, based on a standard health screening questionnaire (called the PAR-Q)
  • People who are currently taking medications that could affect thinking or memory, such as steroids or benzodiazepines
  • People who are currently pregnant
  • People who cannot safely have an MRI scan, such as those with certain metal implants or electronic devices in their body that are not considered MRI-safe
  • People with severe difficulties with thinking or memory, as measured by a specific cognitive screening tool (called the TICS-M)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Carly Wender, PhD, Kessler Foundation

Phone: (973) 324-8388

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Kessler Foundation
Registry
ClinicalTrials.gov
Start date
12 February 2024
Est. completion
30 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in objective new learning and memory (NLM).; Change in everyday memory

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov